Companies/US/MNKD

MANNKIND CORPORATION

Last · NASDAQ$3.02-0.03 (-0.98%)close · yahoo · 13h ago
Vol 7.93M ≈ 23.96M
Market cap$971.06M321.5M sh
P/E · TTM-21.6fwd 23.7 · eps -0.14 · loss
Beta1.08vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.23$6.51
Volume7.9Msession

Issuer

Legal nameMANNKIND CORPORATION
HQUnited States (US)
ListingUS MNKD
ISINUS56400P7069
LEI213800GFBCNY1ZFST722
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0000899460
CIK0000899460
Websitewww.mannkindcorp.com
Employees592
AddressMannKind Corp. 1 Casper Street 06810, Danbury +818 661 5000
Headline financial metrics
Revenue$199.5M
Operating income$-2.0M
Net income$-35.7M
Free cash flow$-30.7M
Operating margin-1.0%
Net margin-17.9%
Period2026
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.00
Est. revenue
110.3M
View upcoming earnings →

Press & signals

3 recent
  • GlobeNewswire

    MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

  • GlobeNewswire

    MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update

  • GlobeNewswire

    MannKind Announces $50 Million Private Placement

Documents

FormReporting forFiledFlags
4
2026-09-252026-09-280
4
2026-09-102026-09-140
10-Q
2026-06-302026-08-05 4
8-K8-K: Unregistered Sales of Equity Securities
2026-07-232026-07-240
Showing 4 of 4 filings